Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-(2-hydroxy-3,5-dibromobenzylamino)cyclohexanol
2. 4'-hdbc
3. 4-((3,5-dibromo-2-hydroxybenzyl)amino)cyclohexanol
4. Dembrexine Hydrochloride, (trans)-isomer
5. Sputolosin
1. Dembroxol
2. 83200-09-3
3. Sputolosin
4. 2,4-dibromo-6-[[(4-hydroxycyclohexyl)amino]methyl]phenol
5. Trans-4-((3,5-dibromosalicyl)amino)cyclohexanol
6. Dembrexine (inn)
7. 4f61f502t5
8. Dembrexine [inn]
9. 2,4-dibromo-6-{[(4-hydroxycyclohexyl)amino]methyl}phenol
10. Dembrexina
11. Dembrexinum
12. Dembroxolum
13. Dembrexinum [latin]
14. Dembrexina [spanish]
15. Dembrexine [inn:ban]
16. Dembrexin
17. Unii-4f61f502t5
18. Sputolosin (tn)
19. Dembrexine [mart.]
20. Schembl1815355
21. Schembl9247816
22. 4,6-dibrom-2(trans-4-hydroxycyclohexylaminomethyl)phenol
23. Chembl2106163
24. Dtxsid10868698
25. Trans-4'-(2-hydroxy-3,5-dibromo-benzylamino)cyclohexanol
26. 4,6-dibromo-alpha-(trans-4-hydroxycyclohexylamino)-o-cresol
27. Dtxsid301016398
28. Zinc261506599
29. Ncgc00538143-01
30. D07786
31. Q27259509
| Molecular Weight | 379.09 g/mol |
|---|---|
| Molecular Formula | C13H17Br2NO2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 378.96055 g/mol |
| Monoisotopic Mass | 376.96260 g/mol |
| Topological Polar Surface Area | 52.5 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dembrexine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dembrexine, including repackagers and relabelers. The FDA regulates Dembrexine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dembrexine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dembrexine supplier is an individual or a company that provides Dembrexine active pharmaceutical ingredient (API) or Dembrexine finished formulations upon request. The Dembrexine suppliers may include Dembrexine API manufacturers, exporters, distributors and traders.
Dembrexine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dembrexine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dembrexine GMP manufacturer or Dembrexine GMP API supplier for your needs.
A Dembrexine CoA (Certificate of Analysis) is a formal document that attests to Dembrexine's compliance with Dembrexine specifications and serves as a tool for batch-level quality control.
Dembrexine CoA mostly includes findings from lab analyses of a specific batch. For each Dembrexine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dembrexine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dembrexine EP), Dembrexine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dembrexine USP).
LOOKING FOR A SUPPLIER?
